Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Pegloticase> ?p ?o }
Showing triples 1 to 87 of
87
with 100 triples per page.
- Pegloticase abstract "Pegloticase (trade name Krystexxa, formerly Puricase) is a drug for the treatment of severe, treatment-refractory, chronic gout, developed by Savient Pharmaceuticals.In September 2010, the FDA approved pegloticase for marketing in the United States after two clinical trials demonstrated the drug lowered uric acid levels and reduced deposits of uric acid crystals in joints and soft tissue. The European Medicines Agency (EMA) granted marketing authorization in January 2013 for treatment of disabling tophaceous gout. Pegloticase is the first drug approved for this indication. Krystexxa is currently marketed in the U.S. by Crealta Pharmaceuticals LLC.The drug is administered by infusion intravenously under the direction of a rheumatologist.".
- Pegloticase atcPrefix "M04".
- Pegloticase atcSuffix "AX02".
- Pegloticase casNumber "885051-90-1".
- Pegloticase fdaUniiCode "R581OT55EA".
- Pegloticase wikiPageExternalLink KRYSTEXXA_Prescribing_Information.pdf.
- Pegloticase wikiPageID "22191540".
- Pegloticase wikiPageLength "5803".
- Pegloticase wikiPageOutDegree "20".
- Pegloticase wikiPageRevisionID "675480344".
- Pegloticase wikiPageWikiLink Allantoin.
- Pegloticase wikiPageWikiLink Amino_acid.
- Pegloticase wikiPageWikiLink Atomic_mass_unit.
- Pegloticase wikiPageWikiLink Category:Antigout_agents.
- Pegloticase wikiPageWikiLink Ethylene_glycol.
- Pegloticase wikiPageWikiLink European_Medicines_Agency.
- Pegloticase wikiPageWikiLink Gout.
- Pegloticase wikiPageWikiLink Immunogenicity.
- Pegloticase wikiPageWikiLink Intravenous.
- Pegloticase wikiPageWikiLink Intravenous_therapy.
- Pegloticase wikiPageWikiLink KDa.
- Pegloticase wikiPageWikiLink Lysine.
- Pegloticase wikiPageWikiLink PEGylated.
- Pegloticase wikiPageWikiLink PEGylation.
- Pegloticase wikiPageWikiLink Pegylated.
- Pegloticase wikiPageWikiLink Porcine.
- Pegloticase wikiPageWikiLink Rasburicase.
- Pegloticase wikiPageWikiLink Savient_Pharmaceuticals.
- Pegloticase wikiPageWikiLink Savient_pharmaceuticals.
- Pegloticase wikiPageWikiLink Suidae.
- Pegloticase wikiPageWikiLink Tetramer.
- Pegloticase wikiPageWikiLink Urate_oxidase.
- Pegloticase wikiPageWikiLink Uric_acid.
- Pegloticase wikiPageWikiLink Uricase.
- Pegloticase wikiPageWikiLinkText "Krystexxa".
- Pegloticase wikiPageWikiLinkText "Pegloticase".
- Pegloticase wikiPageWikiLinkText "pegloticase".
- Pegloticase atcPrefix "M04".
- Pegloticase atcSuffix "AX02".
- Pegloticase bioavailability "N/A".
- Pegloticase casNumber "885051".
- Pegloticase chembl "1237025".
- Pegloticase chemicalFormula "C1549H2430N408O448S8".
- Pegloticase chemspiderid "NA".
- Pegloticase eliminationHalfLife "-1036800.0".
- Pegloticase hasPhotoCollection Pegloticase.
- Pegloticase iupharLigand "7463".
- Pegloticase kegg "D09316".
- Pegloticase legalUs "Rx-only".
- Pegloticase licenceUs "Pegloticase".
- Pegloticase medlineplus "a611015".
- Pegloticase molecularWeight "497".
- Pegloticase pregnancyUs "C".
- Pegloticase routesOfAdministration Intravenous.
- Pegloticase routesOfAdministration Intravenous_therapy.
- Pegloticase tradename "Krystexxa".
- Pegloticase unii "R581OT55EA".
- Pegloticase verifiedfields "changed".
- Pegloticase verifiedrevid "458268850".
- Pegloticase wikiPageUsesTemplate Template:Antigout_preparations.
- Pegloticase wikiPageUsesTemplate Template:Drugbox.
- Pegloticase wikiPageUsesTemplate Template:Musculoskeletal-drug-stub.
- Pegloticase wikiPageUsesTemplate Template:Reflist.
- Pegloticase subject Category:Antigout_agents.
- Pegloticase hypernym Drug.
- Pegloticase type Agent.
- Pegloticase type Article.
- Pegloticase type ChemicalSubstance.
- Pegloticase type Drug.
- Pegloticase type Agent.
- Pegloticase type Article.
- Pegloticase type Chemical.
- Pegloticase type Drug.
- Pegloticase type ChemicalObject.
- Pegloticase type Thing.
- Pegloticase type Q8386.
- Pegloticase comment "Pegloticase (trade name Krystexxa, formerly Puricase) is a drug for the treatment of severe, treatment-refractory, chronic gout, developed by Savient Pharmaceuticals.In September 2010, the FDA approved pegloticase for marketing in the United States after two clinical trials demonstrated the drug lowered uric acid levels and reduced deposits of uric acid crystals in joints and soft tissue.".
- Pegloticase label "Pegloticase".
- Pegloticase sameAs بغلوتيكاز.
- Pegloticase sameAs Pegloticasa.
- Pegloticase sameAs ペグロティカーゼ.
- Pegloticase sameAs Pegloticase.
- Pegloticase sameAs m.05q5wdv.
- Pegloticase sameAs Q7160794.
- Pegloticase sameAs Q7160794.
- Pegloticase wasDerivedFrom Pegloticase?oldid=675480344.
- Pegloticase isPrimaryTopicOf Pegloticase.